Research Topics
Species | George DangasSummaryAffiliation: Columbia University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial)George Dangas
Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY, USA
Am Heart J 155:1090-6. 2008..The value of distal protection devices during rescue PCI has not been studied...
Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial)Kenichi Tsujita
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 105:1385-94. 2010..Paradoxically, in this post hoc analysis, the reductions in major bleeding and mortality in ST elevation myocardial infarction afforded by bivalirudin occurred primarily in patients without baseline anemia...
Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial)Kenji Goto
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 108:1387-94. 2011..Bivalirudin monotherapy compared to UFH plus a GPI decreased major bleeding regardless of smoking status but may have different effects on individual components of ischemic events...
Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis modelNicholas N Kipshidze
Department of Interventional Cardiac and Vascular Services, Lenox Hill Hospital, New York, NY 10021, USA
Catheter Cardiovasc Interv 64:389-94. 2005..001). In the porcine coronary model, site-specific systemic delivery of Rapamycin utilizing PGMC resulted in overexpression of p27 and a significant reduction of neointimal formation within the stented segments...
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trialGregg W Stone
New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10022, USA
Lancet 377:2193-204. 2011..Primary results of the HORIZONS-AMI trial have been previously reported. In this final report, we aimed to assess 3-year outcomes...
Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromesUsman Baber
Mount Sinai Medical Center, New York, New York, USA
JACC Cardiovasc Imaging 5:S53-61. 2012..This study sought to evaluate the impact of chronic kidney disease (CKD) on coronary atherosclerotic plaque composition, morphology, and outcomes in patients with acute coronary syndromes (ACS)...
Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasoundMasashi Kimura
The Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 98:436-42. 2006..Although most ISAs after SES implantation do not resolve completely, the incidence of restenosis or thrombosis is not affected...
Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialGeorge Dangas
Columbia University Medical Center, New York, New York Cardiovascular Research Foundation, New York, New York 10022, USA
J Am Coll Cardiol 54:1438-46. 2009....
Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaqueKenichi Fujii
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
Am J Cardiol 95:355-9. 2005..Plaque rupture morphology is associated with higher periprocedural CK-MB release and worse 1-year clinical outcome in patients treated with coronary stenting...
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarctionGregg W Stone
Columbia University Medical Center and New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 360:1946-59. 2009....
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound studyIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 42:1900-5. 2003..Increased periprocedural CK-MB release appears as a trade-off for optimal stent implantation and lower clinical restenosis...
Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosisKazuyuki Shirai
Cardiovascular Research Foundation, Lenox Hill Hospital, New York, New York 10022, USA
Am J Cardiol 92:1409-13. 2003..In matched lesions, beta and gamma VBT achieved similar reductions in treated segment restenosis and recurrent lesion length compared with placebo...
Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis modelNicholas N Kipshidze
Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
Catheter Cardiovasc Interv 61:518-27. 2004..In the porcine coronary model, an advanced c-myc-eluting PC stent blocked c-myc expression and significantly inhibited myointimal hyperplasia and allowed complete reendothelialization and healing response...
Bivalirudin during primary PCI in acute myocardial infarctionGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 358:2218-30. 2008..The safety and efficacy of bivalirudin in high-risk patients are unknown...
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound studyKenichi Fujii
Cardiovascular Research Foundation, Columbia University Medical Center, 55 East 59th Street, New York, NY 10022, USA
J Am Coll Cardiol 45:995-8. 2005..03) and a significant residual reference segment stenosis (p = 0.02). CONCLUSIONS: Stent underexpansion and residual reference segment stenosis are associated with stent thrombosis after successful SES implantation...
Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protectionDale T Ashby
Lenox Hill Heart and Vascular Institute, New York, New York, USA
J Am Coll Cardiol 41:749-52. 2003..It appears that distal embolic protection may not be necessary during PCI of ISR lesions in degenerated SVGs...
The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationaleRoxana Mehran
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10032, USA
Am Heart J 156:44-56. 2008..Newer pharmacologic agents and drug-eluting stents may address both of these issues...
Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndromeEduardo Missel
Cardiovascular Research Foundation, Columbia University Medical Center, New York, NY, USA
Am J Cardiol 101:573-8. 2008..01) than patients with no predictors. In conclusion, VH-IVUS analysis showed that the percentage of NC and its ratio to DC in diseased coronary segments are positively associated with a high-risk ACS presentation...
Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trialPhilippe Genereux
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
EuroIntervention 7:905-16. 2011..There is a paucity of data comparing the TR approach with the TF approach in patients with STEMI treated with primary PCI and contemporary anticoagulant regimens...
Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteriesIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:1171-6. 2003..Therefore, there does not appear to be any "downside" to aggressive stent implantation strategies in small vessels. In contrast, IVUS allows maximization of final lumen dimensions to minimize clinical restenosis...
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validationRoxana Mehran
Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York 10022, USA
J Am Coll Cardiol 44:1393-9. 2004..4% to 55.9% for a low and high risk score, respectively). CONCLUSIONS: The risk of CIN after PCI can be simply assessed using readily available information. This risk score can be used for both clinical and investigational purposes...
Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosisKenichi Fujii
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10021, USA
Circulation 109:1085-8. 2004..03). A gap between SESs was identified in 3 of 11 recurrences versus 1 of 19 nonrecurrent lesions. CONCLUSIONS: Stent underexpansion is a significant cause of failure after SES implantation treatment of ISR...
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent eraTereza Pucelikova
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
Am J Cardiol 101:63-8. 2008..025). In conclusion, our data show that patients with SVG lesions remain a high-risk subgroup with worse outcomes after percutaneous coronary intervention compared with native vessel disease even in the era of drug-eluting stents...
Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)Thosaphol Limpijankit
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 92:315-8. 2003..e., drug-eluting stents) are available. Shorter time from brachytherapy to radiation failure and late thrombosis after brachytherapy were independent predictors of adverse events...
Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteriesDale T Ashby
Cardiovascular Research Foundation, Lenox Hill Heart and Vascualr Institute, New York, New York 10022, USA
Am J Cardiol 89:1162-6. 2002..A stenting strategy for proximal LAD stenoses appears to attenuate the differences of clinical restenosis noted after non-stent PCI...
Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%Makoto Hirose
Cardiovascular Research Foundation, New York, NY 10021, USA
Am J Cardiol 92:141-5. 2003..7) were similar. Negative remodeling is frequently observed in lesions with intermediate stenosis. This suggests that negative remodeling occurs early in lesion formation...
Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcomeIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
Am J Cardiol 93:963-8. 2004..A less aggressive stent implantation strategy in SVGs than in native coronary lesions appears prudent...
Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapyCostantino O Costantini
Cardiovascular Research Foundation, New York, New York 10021, USA
Am J Cardiol 92:1214-7. 2003....
5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trialGregg W Stone
Department of Medicine, Division of Cardiology, Columbia University, Medical Center New York Presbyterian Hospital, Cardiovascular Research Foundation, New York 10022, USA
JACC Cardiovasc Interv 4:300-9. 2011..We sought to evaluate the utility of the JOSTENT polytetrafluoroethylene (PTFE) stent-graft (Jomed GmbH, Rangendingen, Germany) in patients with diseased saphenous vein grafts (SVGs) undergoing percutaneous coronary intervention (PCI)...
Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary graDinesh Kumar
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 106:941-5. 2010....
Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomesIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
Catheter Cardiovasc Interv 62:303-7. 2004..DM remains a powerful predictor of TLR and major adverse cardiac events even after treatment of ISR with gamma-RT...
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationaleGregg W Stone
Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
Am Heart J 148:764-75. 2004..Pilot trials suggest that the thrombin-specific anticoagulant bivalirudin may improve clinical outcomes in ACS...
The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary interventionAdam J Saltzman
Cardiovascular Medicine and the Center for Interventional Vascular Therapy, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY, 10032, USA
J Invasive Cardiol 22:2-6. 2010..We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI)...
Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trialsSomjot S Brar
Columbia University Medical Center, New York, NY, USA
EuroIntervention 5:475-84. 2009....
Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study)George Dangas
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 96:659-63. 2005....
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variablesGeorge Dangas
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
Am J Cardiol 95:13-9. 2005..22 to 2.60). Thus, regardless of the presence of CKD, baseline characteristics and periprocedural hemodynamic parameters predict CIN, and this complication is associated with worse in-hospital and 1-year outcomes...
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventionsEugenia Nikolsky
Cardiovascular Research Foundation, New York, New York, USA
Kidney Int 67:706-13. 2005..Whether correcting the hematocrit prepercutaneous coronary intervention might decrease the rates of contrast-induced nephropathy should be addressed in a prospectively designed trial...
Intravascular ultrasound study of patterns of calcium in ruptured coronary plaquesKenichi Fujii
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 96:352-7. 2005..In conclusion, ruptured plaques are associated with a larger number of calcium deposits within an arc of <90 degrees , a larger number of deep calcium deposits, and a remodeling index...
Gamma radiation for in-stent restenosis: effect of lesion length on angiographic and clinical outcomesRoxana Mehran
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Catheter Cardiovasc Interv 61:354-9. 2004..Lesion length remains a powerful predictor of recurrent ISR and clinical events after treatment of ISR even with gamma-RT...
Intravascular brachytherapy for native coronary ostial in-stent restenotic lesionsCostantino O Costantini
Cardiovascular Research Foundation, Lenox Hill Hospital, 55 East 59th Street, 6th Floor, New York, New York, NY 10022, USA
J Am Coll Cardiol 41:1725-31. 2003..Vascular brachytherapy with either gamma or beta sources results in significant and similar reductions in restenosis compared with placebo. Similar benefits after VBT prevail in true aorto-ostial lesions...
Female gender and mortality after percutaneous coronary intervention: results from a large registryJason C Kovacic
Cardiovascular Institute, Mount Sinai Medical Center, New York, New York 10029, USA
Catheter Cardiovasc Interv 80:514-21. 2012..To investigate if previously reported gender-based outcome disparities following percutaneous coronary intervention (PCI) are applicable in a large and racially-diverse cohort in the drug eluting stent (DES) era...
Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years oldYoshio Kobayashi
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:443-6. 2003....
Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of ageIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:1083-6. 2003..5% were >or=75 years of age. Compared with patients <75 years old, those >or=75 years of age had similar procedural and in-hospital outcomes but significantly higher rates of hemorrhagic stroke (0.08% vs 1.2%, p <0.001)...
Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromesKenichi Fujii
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, 130 East 77th St, 9th Floor, New York, NY 10021, USA
Circulation 108:2473-8. 2003..Plaque rupture itself does not lead to symptoms. The association of plaque rupture with a smaller lumen area and/or thrombus formation causes lumen compromise and leads to symptoms...
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)Ricardo A Costa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
Am J Cardiol 95:113-6. 2005..There was 1 in-stent and 1 in-segment (proximal edge) restenosis in the metallic stent group. There was no stent thrombosis or aneurysm formation at follow-up in either group...
Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosisYoshio Kobayashi
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:1329-31. 2003..02) but similar target vessel revascularization (35.1% vs 29.8%, p = 0.4) at follow-up...
Comparison of frequency of hemorrhagic stroke in patients <75 years versus > or =75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventionsIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 93:346-9. 2004..5%) were aged > or =75 years (253 procedures, 430 lesions). Very elderly patients (> or =75 years) had similar in-hospital outcomes but a higher hemorrhagic stroke rate than patients aged <75 years...
Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesionsJason C Kovacic
The Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, United States
Atherosclerosis 221:176-82. 2012..We sought to explore this hypothesis in a large group of patients with coronary artery disease undergoing percutaneous coronary intervention (PCI)...
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trialsJeffrey W Moses
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10032, USA
J Am Coll Cardiol 47:2164-71. 2006....
Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysisEugenia Nikolsky
Cardiovascular Research Foundation and the Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 44:1200-9. 2004..79). CONCLUSIONS: In the setting of Dx angiography, the risk of access-site-related complications was similar for ACD compared with mechanical compression. In the setting of PCI, the rate of complications appeared higher with VasoSeal...
Relation between the degree of procedural anticoagulation and complications after coronary stent implantationDale T Ashby
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:319-22. 2003..High levels of procedural anticoagulation with heparin were found to increase hemorrhagic complications without improving clinical or angiographic outcomes...
Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approachEugenia Nikolsky
Cardiovascular Research Foundation, Columbia University Medical Center, Herbert Irving Pavilion, 5th Floor, 161 Fort Washington Avenue, New York, NY 10032, USA
Eur Heart J 28:1936-45. 2007..Major bleeding after percutaneous coronary intervention (PCI) is an independent risk factor for early and late mortality. We developed and validated a risk score predictive of major bleeding after PCI using the femoral approach...
Is accurate intravascular ultrasound evaluation of the left circumflex ostium from a left anterior descending to left main pullback possible?Carlos Oviedo
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 105:948-54. 2010..For an accurate assessment of the side branch ostium, direct imaging is necessary...
Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary interventionIoannis Iakovou
Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY, 10022, USA
J Invasive Cardiol 15:18-22. 2003..Contrast-induced nephropathy (CIN) is a recognized complication after percutaneous interventions (PCI). We sought to determine the impact of gender on incidence and clinical outcome of CIN...
Vascular remodeling and plaque composition between focal and diffuse coronary lesions assessed by intravascular ultrasoundKenichi Fujii
Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York 10032, USA
Am J Cardiol 94:1067-70. 2004..Negative remodeling and fibrous and calcified plaque compositions contribute to stenosis development in diffuse lesions more frequently than in focal lesions...
Dominant contribution of negative remodeling to development of significant coronary bifurcation narrowingKenichi Fujii
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10021, USA
Am J Cardiol 92:59-61. 2003
Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque ruptureLisette Okkels Jensen
Cardiovascular Research Foundation, New York, NY 10022, USA
Am Heart J 152:327-32. 2006....
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part IGregg W Stone
Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
Circulation 112:2364-72. 2005
Successful use of the frontrunner catheter in the treatment of in-stent coronary chronic total occlusionsYi-ming Yang
Columbia University Medical Center and Cardiovascular Research Foundation, 161 Fort Washington Avenue, New York, NY 10032, USA
Catheter Cardiovasc Interv 63:462-8. 2004..TIMI 3 flow was achieved in all target vessels after further balloon angioplasty or stenting. The Frontrunner device is a safe and effective tool in the treatment of CTOs from ISR...
Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance chartsJose de Ribamar Costa
Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 96:74-8. 2005..These differences are independent of stent manufacturer, length, diameter, and deployment pressure...
Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesionHideo Takebayashi
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Catheter Cardiovasc Interv 60:496-9. 2003..This case report describes in-stent restenosis due to stent underexpansion after kissing stents using sirolimus-eluting stents...
Percutaneous recanalization of chronically occluded coronary arteries: procedural techniques, devices, and resultsGregg W Stone
Division of Cardiology, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
Catheter Cardiovasc Interv 66:217-36. 2005
Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the Peripheral Arterial Disease in Interventional Patients StudyIssam D Moussa
Division of Cardiology, New York Presbyterian Hospital Weill Cornell Medical Center, Weill Medical College of Cornell University, New York, New York, USA
Catheter Cardiovasc Interv 73:719-24. 2009..Peripheral arterial disease (PAD) is under diagnosed in primary care practices, yet the extent of unrecognized PAD in patients with coronary artery disease (CAD) is unknown...
Impact of anemia on outcomes of patients undergoing percutaneous coronary interventionsEugenia Nikolsky
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
Am J Cardiol 94:1023-7. 2004..8% vs 3.5%). After adjustment for potential confounders, baseline hematocrit remained a significant predictor of a 1-year mortality rate (hazard ratio 0.93 per 1% increase in hematocrit, 95% confidence interval 0.91 to 0.95)...
Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteriesDale T Ashby
Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
Am J Cardiol 91:979-81, A4, A7. 2003
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part IIGregg W Stone
Columbia University Medical Center, The Cardiovascular Research Foundation, New York, NY 10022, USA
Circulation 112:2530-7. 2005
Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agentsJorge Magallon
Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA
Circulation 123:319-26. 2011..Here, we evaluate the use of this biological platform as a pharmacodynamic biomarker for antithrombotic therapies...
Coronary artery spasm associated with a moderately severe atherosclerotic stenosis in the proximal LADDale T Ashby
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Invasive Cardiol 14:770-2. 2002..We discuss the diagnostic value of intravascular ultrasound and treatment options for spasm associated with atherosclerotic plaques...
Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary arteryGeorge Dangas
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
J Am Coll Cardiol 45:1186-92. 2005..Notably, the need for bypass graft surgery due to restenosis is reduced after TAXUS stent implantation in LAD lesions...
Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiationAlexandra J Lansky
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 39:274-80. 2002....
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)George Dangas
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 94:983-8. 2004..The incidence of early thrombosis after primary angioplasty and stenting is decreased by abciximab use...
Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitorsIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 89:976-9. 2002
Acute angiographic and clinical results of the NIR w/SOX stentYoshio Kobayashi
Lenox Hill Heart and Vascular Institute, 130 East 77th Street, New York, NY 10021, USA
J Invasive Cardiol 14:14-8. 2002..Furthermore, it may have a high probability to be delivered in lesions where other kinds of stent result in unsuccessful delivery...
Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis modelNicholas N Kipshidze
Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, 130 East 77th Street, Black Hall, 9th Floor, New York, NY 10021, USA
Cardiovasc Radiat Med 4:152-9. 2003..The purpose of this study was to investigate the effects of perfluorocarbon gas microbubble carrier (PGMC)-based systemic delivery of AVI-4126 on expression of the c-myc in vascular tissue and restenosis after stent implantation...
Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloonJose de Ribamar Costa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 100:812-7. 2007..In conclusion, in this observational, nonrandomized study, pretreatment with the AngioSculpt balloon enhanced stent expansion and minimized the difference between predicted and achieved stent dimensions...
Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysisKoichi Sano
Cardiovascular Research Foundation, 611 Pennsylvania Avenue, S E, No 386, Washington, D C, USA
J Invasive Cardiol 19:464-8. 2007..The intravascular ultrasound (IVUS) findings during repeat intervention for drug-eluting stent (DES) restenosis have not been well described...
PCI options in heparin-induced thrombocytopeniaGeorge Dangas
Cardiovascular Research Foundation, Lenox Hill Heart Vascular Institute, New York, NY 10022, USA
J Invasive Cardiol 15:622-3. 2003
Pulmonary hemorrhage during GP IIb/IIIa inhibitor therapy: an uncommon but life-threatening (and under-recognized) complicationGeorge Dangas
Lenox Hill Heart and Vascular Institute, Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
J Invasive Cardiol 15:189-90. 2003
Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis modelNicholas N Kipshidze
Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
J Am Coll Cardiol 39:1686-91. 2002..We evaluated the long-term influence of intramural delivery of advanced c-myc neutrally charged antisense oligonucleotides (Resten-NG) on neointimal hyperplasia after stenting in a pig model...
Intravascular ultrasound classification of plaque distribution in left main coronary artery bifurcations: where is the plaque really located?Carlos Oviedo
Cardiovascular Research Foundation and Columbia University Medical Center, 111 East 59th Street, New York, NY 10022, USA
Circ Cardiovasc Interv 3:105-12. 2010..Angiographic classifications of the location and severity of disease in the main vessel and side branch of coronary artery bifurcations have been proposed and applied to distal left main coronary artery (LMCA) bifurcation...
Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending arteryIoannis Iakovou
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 90:885-7. 2002
Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysisSomjot S Brar
Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York 10032, USA
J Am Coll Cardiol 53:1677-89. 2009..A secondary analysis was performed among registry studies...
Complete vascular healing and sustained suppression of neointimal thickening after local delivery of advanced c-myc antisense at six months follow-up in a rabbit balloon injury modelNicholas Kipshidze
Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, NY 10021, USA
Cardiovasc Radiat Med 3:26-30. 2002..We evaluated the long-term impact of local delivery of c-myc neutrally charged antisense oligonucleotides (Resten-NG) upon neointimal formation following PTCA in a rabbit model...
Interventional therapy for acute myocardial infarction: respect the microvasculatureGeorge Dangas
J Am Coll Cardiol 42:1403-5. 2003
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stentingDeepak L Bhatt
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
J Am Coll Cardiol 39:9-14. 2002..Therefore, clopidogrel plus aspirin should replace ticlopidine plus aspirin as the standard antiplatelet regimen after stent deployment...
Clinical outcome following percutaneous coronary interventions in patients with chronic renal failureLuis Gruberg
Department of Cardiology, Rambam Medical Center, Haifa, Israel
Catheter Cardiovasc Interv 55:66-72. 2002..0001), and CRF (OR = 1.74; P = 0.003) were independent correlates of increased late mortality. Therefore, PCI in patients with impaired renal function, whether on dialysis or not, is associated with poor in-hospital and 1-year survival...
Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary interventionEmilia Solinas
Division of Cardiology, Parma University Hospital, Italy
Am J Cardiol 102:311-5. 2008..Treatment with either repeated DES implantation or balloon angioplasty for DES-ISR was safe and associated with low overall rates of target-lesion revascularization and major adverse cardiac events at 1 year...
Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy)Paul S Teirstein
Scripps Clinic, La Jolla, California, USA
Am J Cardiol 96:500-5. 2005..By multivariate analysis, use of GP IIb/IIIa inhibitors during stenting with the TAXUS stent was an independent predictor of CK-MB increases >3 times the normal level. Further studies are warranted...
An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary interventionEugenia Nikolsky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, NY 10022, USA
J Invasive Cardiol 19:208-13. 2007..We evaluated short-term prognosis and resource utilization of consecutive patients treated with percutaneous coronary intervention (PCI) as a function of fluoroscopy time...
Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trialsStuart J Pocock
London School of Hygiene and Tropical Medicine, London, United Kingdom
J Am Coll Cardiol 51:23-32. 2008..We sought to validate 4 angiographic measures as potential surrogates for clinical restenosis (target lesion revascularization [TLR]) after stent implantation...
Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarctionGregg W Stone
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 39:591-7. 2002..We sought to evaluate and validate the ability of the angiographic myocardial blush grade to risk stratify patients after successful angioplasty in acute myocardial infarction (AMI)...
Clopidogrel loading dose pre-PCI: how high?Eugenia Nikolsky
J Invasive Cardiol 16:551-2. 2004
Editorial commentary: in-stent restenosis and cutting balloonGeorge Dangas
J Invasive Cardiol 14:297-8. 2002
